PART I Overview Throughout our history, we have advanced the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is natures most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our immune medicine platform applies our proprietary technologies to read th...
Q2 FY2026 — expected 2026-08-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076902 | EDGAR | 86K words |
| 2025-03-03 | 2024-12-31 | 0000950170-25-030913 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0000950170-24-023095 | EDGAR | — |
| 2023-02-14 | 2022-12-31 | 0000950170-23-002792 | EDGAR | — |
| 2022-02-15 | 2021-12-31 | 0001564590-22-005228 | EDGAR | — |
| 2021-02-24 | 2020-12-31 | 0001564590-21-008124 | EDGAR | — |
| 2020-02-26 | 2019-12-31 | 0001564590-20-006830 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-04 | 2026-06-30 | 0001193125-26-332940 | EDGAR | 29K words |
| 2025-11-05 | 2025-09-30 | 0001193125-25-267061 | EDGAR | 28K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-103120 | EDGAR | — |
| 2025-05-01 | 2025-03-31 | 0000950170-25-061897 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123423 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0000950170-24-089342 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0000950170-24-054604 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062136 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0000950170-23-037234 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0000950170-23-017250 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021923 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001564590-22-027784 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-29 | 0001193125-26-323753 | EDGAR | — |
| 2026-02-05 | 0001193125-26-039409 | EDGAR | 4K words |
| 2026-01-12 | 0001193125-26-009840 | EDGAR | — |
| 2025-12-30 | 0001193125-25-335921 | EDGAR | — |
| 2025-11-05 | 0001193125-25-266974 | EDGAR | — |
| 2025-08-18 | 0001193125-25-182222 | EDGAR | — |
| 2025-08-05 | 0000950170-25-103058 | EDGAR | — |
| 2025-06-12 | 0001193125-25-140017 | EDGAR | — |
| 2025-05-01 | 0000950170-25-061851 | EDGAR | — |
| 2025-02-11 | 0000950170-25-017915 | EDGAR | — |
109 total filings indexed. 80 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001478320 |
| Ticker | ADPT |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | WA |
| Website | https://www.adaptivebiotech.com |
| Listed | 2019-06-27 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ADPT (~200 tokens, structured JSON with cryptographic provenance)